Abstract

Monascus fermentation products can be consumed as food or feed supplements or used as food colouring or flavouring agents. In this study, qPCR and Q-TOF LC/MS methods were developed to monitorMonascus ruber andMonascus purpureus growth and extrolite (lovastatin, mevastatin, as well as the regulated mycotoxin, citrinin (CIT)) production, respectively. Wheat kernels were inoculated with one strain of each species during a solid-state fermentation followed over 63 days. Different growth and extrolite production patterns were clearly observed for the 2 tested strains. After 63 days, high lovastatin levels (up to 0.5 mg/g) were reached forM. ruber wheat fermented kernels whileM. purpureus only yielded 0.1 mg/g of lovastatin at best, suggesting thatM. ruber may be a better candidate for lovastatin production in a wheat-based model. Mevastatin levels were low and stable for both species. However,M. ruber fermented wheat kernels also contained the highest CIT content, up to 4.2 μg/g, i.e. at levels above the regulation threshold set by the European Union. CIT toxicity was then determinedin vitro on bovine kidney cells, showing an IC10 of 6.10-4 M. At maximum concentrations encountered during solid-state fermentation, CIT toxicity was very low under chronic exposure.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.